Roche Holding AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
Phase 4
Completed
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 205
- Registration Number
- NCT00577031
A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.
Phase 3
Completed
- Conditions
- Anemia
- Interventions
- Drug: methoxy polyethylene glycol-epoetin beta [C.E.R.A.]
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 133
- Registration Number
- NCT00576628
A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer
Phase 2
Completed
- Conditions
- Liver Cancer
- Interventions
- Procedure: Transarterial chemoembolisation (TACE)
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2014-08-29
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 30
- Registration Number
- NCT00576199
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.
Phase 2
Terminated
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2014-08-11
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 23
- Registration Number
- NCT00576901
Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal Rate
Not Applicable
Completed
- Conditions
- Diabetes Mellitus Type 1
- Interventions
- Device: Accu-Chek Spirit Insulin Pump
- First Posted Date
- 2007-12-07
- Last Posted Date
- 2016-03-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 12
- Registration Number
- NCT00569452
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 34
- Registration Number
- NCT00560144
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Phase 3
Completed
- Conditions
- Anemia
- Interventions
- Drug: methoxy polyethylene glycol-epoetin beta [Mircera]
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2016-04-12
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 233
- Registration Number
- NCT00560404
A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2016-08-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00560547
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
Phase 4
Completed
- Conditions
- Anemia
- Interventions
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 190
- Registration Number
- NCT00560274
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
Phase 3
Completed
- Conditions
- Renal Anemia, Chronic
- Interventions
- First Posted Date
- 2007-11-16
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 307
- Registration Number
- NCT00559273
© Copyright 2025. All Rights Reserved by MedPath